The Liver Transplant Generalist: MELD and Coagulopathy

The Liver Precipice: Beyond the MELD Score

If you're like me, seeing a patient with a MELD of 35 on your schedule makes you check your blood inventory twice. You’ve probably seen the "typical" liver patient: jaundiced, ascitic, and one minor bleed away from the ICU. The reality is, for the anesthesiology oral boards, you don't need to be a transplant surgeon, but you must think like a vascular and critical care consultant.

The Cliff: The Coagulopathy Myth

A major trap on the boards is assuming that an INR of 3.0 means the patient is "auto-anticoagulated." The reality is more complex: they are rebalanced, but that balance is incredibly fragile. They are missing both pro-coagulants and anti-coagulants. If you blindly chase numbers with FFP, you risk volume overload and worsening portal hypertension. "I will utilize point-of-care testing, specifically TEG or ROTEM, to guide my transfusion strategy rather than relying on static lab values like PT/INR, which poorly reflect the actual clotting capacity in ESLD."

The Pivot: The "Stage" Logic

Divide your transplant (or major liver resection) logic into three distinct physiological hurdles:

• Pre-Anhepatic: Focus on volume management and avoiding renal insults (HRS prevention).
• Anhepatic: The "metabolic dark age." Acidosis, hypocalcemia, and hyperkalemia are the enemies here.
• Neo-Anhepatic (Reperfusion): The "Post-Reperfusion Syndrome." Be ready for the massive drop in SVR and the surge of potassium. "I will have calcium chloride and epinephrine ready at the moment of unclamping."

Conclusion: Managing the "Sickest of the Sick"

Liver failure is a systemic disease. It’s a heart issue (cirrhotic cardiomyopathy), a lung issue (Hepatopulmonary Syndrome), and a kidney issue. Practice defending these multi-system complexities in the Oral Boards Bot to ensure you can explain the why behind your restrictive fluid strategy.